
Servier has been found guilty of the most serious breach of the UK’s pharma code of conduct after failing to …

Most people in the pharmaceutical industry, particularly in the UK, will be well-acquainted with Ben Goldacre by now. He published his …

UCB chief executive Roch Doliveux has attacked the idea of making all clinical trial data publicly available, saying it could …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

